Search Videos and More
Showing 1 - 3 of 3 results
Video
Phenotype, Specificity and Avidity of Antitumour CD8+ T Cells in Melanoma
Dana-Farber's Giacomo Oliveira, PhD describes a study he led with Cathy Wu, MD, that appeared in Nature.
Document
Melanoma Select Clinical Trials
The listed trials are a sampling of our many open and accruing studies.
News
Personalized Vaccine Produces Long-Lasting Anti-Tumor Response in Patients with Melanoma, Study Shows
Four years after patients with melanoma were treated with a personalized cancer vaccine, the immune response kindled by the vaccine remains robust and effective in keeping cancer cells under control, researchers at Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and the Broad Institute of MIT and Harvard report in a new study.